Psoriatic Arthritis - Market Insights, Epidemiology and Market Forecast - 2025

Publisher Name :
Date: 28-Jul-2017
No. of pages: 70
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Psoriatic Arthritis - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Psoriatic Arthritis for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Psoriatic Arthritis . It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Psoriatic Arthritis for 7 major markets.

The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the Report highlights the frontrunners, the drivers and barriers for the Psoriatic Arthritis market, as well as treatment algorithm, current treatments & advancements are included.The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Psoriatic Arthritis , providing an in-depth analysis of emerging therapies which will create an impact through their launch.

According to DelveInsight, the forecasted patient population of Psoriatic Arthritis for the year 2025 will be XX, increasing at a CAGR of XX% from 2015 to 2025 and the Psoriatic Arthritis 7MM market size is estimated to be USD XX by 2025.The DelveInsight Report will help in enhanced understanding of the Psoriatic Arthritis market from inside out, with transparency into the calculated patient forecasting data and estimated market size.

Key Coverage

  • Understanding historical and forecasted epidemiological data for Psoriatic Arthritis covering 7MM from 2015-2025.

  • Segment level epidemiology and market split for Psoriatic Arthritis .

  • The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Psoriatic Arthritis .

  • The Report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Psoriatic Arthritis market trends.

  • Thorough market distribution based on market share for Psoriatic Arthritis .

Reasons to buy

  • The report will help in developing business strategies by understanding trends shaping and driving the Psoriatic Arthritis market.

  • To understand the future market competition in the Psoriatic Arthritis market and Insightful review of the key market drivers and barriers.

  • Organize sales and marketing efforts by identifying the best opportunities for Psoriatic Arthritis in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.

  • Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.

Psoriatic Arthritis - Market Insights, Epidemiology and Market Forecast - 2025

Table of Contents

1. Report Introduction

2. Psoriatic Arthritis Market Overview at a Glance
2.1. Total Market Share Distribution of Psoriatic Arthritis for 7 MM in 2016
2.2. Total Market Share Distribution of Psoriatic Arthritis for 7 MM in 2025

3. Psoriatic Arthritis
3.1.1. Overview
3.1.2. Symptoms
3.1.3. Pathophysiology
3.1.4. Staging
3.1.5. Diagnosis
3.1.6. Treatment

4. Epidemiology and Patient Population
4.1.1. United States
4.1.1.1. Diagnosed Cases of Psoriatic Arthritis in United States
4.1.2. Germany
4.1.2.1. Diagnosed Cases of Psoriatic Arthritis in Germany
4.1.3. France
4.1.3.1. Diagnosed Cases of Psoriatic Arthritis in France
4.1.4. Italy
4.1.4.1. Diagnosed Cases of Psoriatic Arthritis in Italy
4.1.5. Spain
4.1.5.1. Diagnosed Cases of Psoriatic Arthritis in Spain
4.1.6. United Kingdom
4.1.6.1. Diagnosed Cases of Psoriatic Arthritis in United Kingdom

5. Treatment Algorithm
5.1.1. Treatment Guidelines/Practices

6. Marketed Drugs for Psoriatic Arthritis
6.1. Drug 1: Company A
6.1.1. Drug Description
6.1.2. Mechanism of Action
6.1.3. Regulatory Milestones
6.1.4. Advantages & Disadvantages
6.1.5. Safety and Efficacy
6.1.6. Product Profile
6.1.7. Patent Status
6.2. Drug 2: Company B
6.2.1. Drug Description
6.2.2. Mechanism of Action
6.2.3. Regulatory Milestones
6.2.4. Advantages & Disadvantages
6.2.5. Safety and Efficacy
6.2.6. Product Profile
6.2.7. Patent Status

7. Emerging Therapies
7.1. Drug 3: Company C
7.1.1. Description
7.1.2. Regulatory Milestones
7.1.3. Advantages & Disadvantages
7.1.4. Product Profile
7.1.5. Launch Date
7.1.6. Clinical Development
7.1.7. Clinical Pipeline Activity
7.1.8. Ongoing Trials Information
7.1.9. Clinical Trial by Phase
7.2. Drug 4: Company B
7.2.1. Description
7.2.2. Regulatory Milestones
7.2.3. Advantages & Disadvantages
7.2.4. Product Profile
7.2.5. Launch Date
7.2.6. Clinical Development
7.2.7. Clinical Pipeline Activity
7.2.8. Ongoing Trials Information
7.2.9. Clinical Trial by Phase

8. Overview of Total Psoriatic Arthritis Market (2016 & 2025)

9. Psoriatic Arthritis : Country-Wise Market Analysis
9.1. United States
9.1.1. Historical Market Size (2015-2016)
9.1.2. Forecasted Market Size (2017-2025)
9.2. Germany Market Size
9.2.1. Historical Market Size (2015-2016)
9.2.2. Forecasted Market Size (2017-2025)
9.3. France Market Size
9.3.1. Historical Market Size (2015-2016)
9.3.2. Forecasted Market Size (2017-2025)
9.4. United Kingdom Market Size
9.4.1. Historical Market Size (2015-2016)
9.4.2. Forecasted Market Size (2017-2025)
9.5. Spain Market Size
9.5.1. Historical Market Size (2015-2016)
9.5.2. Forecasted Market Size (2017-2025)
9.6. Italy Market Size
9.6.1. Historical Market Size (2015-2016)
9.6.2. Forecasted Market Size (2017-2025)
9.7. Japan Market Size
9.7.1. Historical Market Size (2015-2016)
9.7.2. Forecasted Market Size (2017-2025)

10. Market Drivers

11. Market Restraints

12. Appendix

13. Report Methodology

14. Consulting Services

15. Disclaimer

16. About DelveInsight

List of Tables

Table 1: Diagnosed Cases Psoriatic Arthritis in United States (2015-2025)
Table 2: Diagnosed Cases Psoriatic Arthritis in Germany (2015-2025)
Table 3: Diagnosed Cases Psoriatic Arthritis in France (2015-2025)
Table 4: Diagnosed Cases Psoriatic Arthritis in United Kingdom (2015-2025)
Table 5: Diagnosed Cases Psoriatic Arthritis in Spain (2015-2025)
Table 6: Diagnosed Cases Psoriatic Arthritis in Italy (2015-2025)
Table 7: Diagnosed Cases Psoriatic Arthritis in Japan (2015-2025)
Table 8: List of Marketed Drugs for Psoriatic Arthritis
Table 9: List of Pipeline Phase III Drugs for Psoriatic Arthritis
Table 10: Drug 1, Clinical Trials by Zone, 2017
Table 11: Clinical Trials by Trial status, 2017
Table 12: Drug 2, Clinical Trials by Zone, 2017
Table 13: Clinical Trials by Trial status, 2017
Table 14: Drug 3, Clinical Trials by Zone, 2017
Table 15: Clinical Trials by Trial status, 2017
Table 16: United States Market Size of Psoriatic Arthritis in USD, Million (2015-2025)
Table 17: Germany Market Size of Psoriatic Arthritis in USD, Million (2015-2025)
Table 18: France Market Size of Psoriatic Arthritis in USD, Million (2015-2025)
Table 19: United Kingdom Market Size of Psoriatic Arthritis in USD, Million (2015-2025)
Table 20: Spain Market Size of Psoriatic Arthritis in USD, Million (2015-2025)
Table 21: Italy Market Size of Psoriatic Arthritis in USD, Million (2015-2025)
Table 22: Japan Market Size of Psoriatic Arthritis in USD, Million (2015-2025)

List of Figures

Figure 1: Diagnosed Cases Psoriatic Arthritis in United States (2015-2025)
Figure 2: Diagnosed Cases Psoriatic Arthritis in Germany (2015-2025)
Figure 3: Diagnosed Cases Psoriatic Arthritis in France (2015-2025)
Figure 4: Diagnosed Cases Psoriatic Arthritis in United Kingdom (2015-2025)
Figure 5: Diagnosed Cases Psoriatic Arthritis in Spain (2015-2025)
Figure 6: Diagnosed Cases Psoriatic Arthritis in Italy (2015-2025)
Figure 7: Diagnosed Cases Psoriatic Arthritis in Japan (2015-2025)
Figure 8: List of Marketed Drugs for Psoriatic Arthritis
Figure 9: List of Pipeline Phase III Drugs for Psoriatic Arthritis
Figure 10: Drug 1, Clinical Trials by Zone (%), 2017
Figure 11: Clinical Trials by Trial status, 2017
Figure 12: Drug 2, Clinical Trials by Zone (%), 2017
Figure 13: Clinical Trials by Trial status, 2017
Figure 14: Drug 3, Clinical Trials by Zone (%), 2017
Figure 15: Clinical Trials by Trial status, 2017
Figure 16: United States Market Size of Psoriatic Arthritis in USD, Million (2015-2025)
Figure 17: Germany Market Size of Psoriatic Arthritis in USD, Million (2015-2025)
Figure 18: France Market Size of Psoriatic Arthritis in USD, Million (2015-2025)
Figure 19: United Kingdom Market Size of Psoriatic Arthritis in USD, Million (2015-2025)
Figure 20: Spain Market Size of Psoriatic Arthritis in USD, Million (2015-2025)
Figure 21: Italy Market Size of Psoriatic Arthritis in USD, Million (2015-2025)
Figure 22: Japan Market Size of Psoriatic Arthritis in USD, Million (2015-2025)
  • Osteoarthritis Pain - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 224
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis Pain - Pipeline Review, H2 2017, provides an overview of the Osteoarthritis Pain (Central Nervous System) pipeline landscape.Osteoarthritis pain is the most common symptom associated with osteoarthritis which causes disruption of the cartilage. If the condition worsens, it leads to rubbing of the bones against each other causing even more pain and loss of movement. Risk factors are age, joint in......
  • Global Arthritis Partnering 2010 to 2017
    Published: 01-Oct-2017        Price: US 1495 Onwards        Pages: 200
    "Delivery of this report will take 1-3 days after purchase." The Global Arthritis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understan......
  • Global Rheumatoid Arthritis Partnering 2010 to 2017
    Published: 01-Oct-2017        Price: US 1495 Onwards        Pages: 200
    "Delivery of this report will take 1-3 days after purchase." The Global Rheumatoid Arthritis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provide......
  • Global Osteoarthritis Partnering 2010 to 2017
    Published: 01-Oct-2017        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Osteoarthritis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides unde......
  • Systemic Idiopathic Juvenile Arthritis - Pipeline Review, H2 2017
    Published: 12-Sep-2017        Price: US 2000 Onwards        Pages: 56
    Systemic Idiopathic Juvenile Arthritis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Idiopathic Juvenile Arthritis - Pipeline Review, H2 2017, provides an overview of the Systemic Idiopathic Juvenile Arthritis (Musculoskeletal Disorders) pipeline landscape. Systemic onset juvenile idiopathic arthritis (also known as Systemic juvenile idiopathic arthritis (sJIA)) is a disor......
  • EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2026
    Published: 04-Sep-2017        Price: US 3995 Onwards        Pages: 50
    EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2026 Summary Osteoarthritis (OA) is a gradually progressive joint disease that is typically seen in middle-aged to elderly people. According to the American College of Rheumatology (ACR), OA is the most common cause of disability in the elderly. The most commonly affected joints are the knee, hip, hand, and spine. It is characterized by breakdown of the cartilage, bony changes of the joints, deterioration of ......
  • Juvenile Idiopathic arthritis (JIA) -Epidemiology Forecast to 2025
    Published: 01-Sep-2017        Price: US 2750 Onwards        Pages: 40
    DelveInsight "Juvenile Idiopathic arthritis (JIA) - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Juvenile Idiopathic arthritis (JIA) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Juvenile Idiopathic arthritis (JIA) prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special......
  • Juvenile Idiopathic arthritis (JIA) - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Sep-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Juvenile Idiopathic arthritis (JIA) - Market Insights, Epidemiology and Market Forecast - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Juvenile Idiopathic arthritis (JIA) - Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the p......
  • Osteoarthritis -Epidemiology Forecast to 2025
    Published: 01-Sep-2017        Price: US 2750 Onwards        Pages: 40
    DelveInsight "Osteoarthritis - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Osteoarthritis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Osteoarthritis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Oste......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs